Otonomy Inc. | Key People and Executives

Jay B. Lichter
Chairman
David A. Weber
President, Chief Executive Officer & Director
James B. Breitmeyer
Director
Iain McGill
Independent Director
Theodore R. Schroeder
Independent Director
George J. Morrow
Independent Director
Vickie L. Capps
Independent Director
Heather Elizabeth Preston
Independent Director
Jay B. Lichter
Chairman
David A. Weber
President, Chief Executive Officer & Director
Paul E. Cayer
Chief Financial, Business & Accounting Officer
Katherine M. Bishop
Chief Scientific Officer
Robert Michael Savel
Chief Technical Officer
James B. Breitmeyer
Director
Iain McGill
Independent Director
Theodore R. Schroeder
Independent Director
George J. Morrow
Independent Director
Vickie L. Capps
Independent Director
Heather Elizabeth Preston
Independent Director

About Otonomy

View Profile
Address
4796 Executive Drive
San Diego California 92121
United States
Employees -
Website http://www.otonomy.com
Updated 07/08/2019
Otonomy, Inc. is a biopharmaceutical company, which engages in the research, development, and manufacture of therapeutics for otology. The firm's portfolio includes therapeutics for diseases and disorders of the ear such as Ménière's disease, tinnitus, synaptopathy hearing loss, cisplatin-induced loss, severe hearing loss, TTP surgery, and acute otitis externa. It operates under the Otiprio brand.